Omega‐3 Polyunsaturated Fatty Acids and Lung Cancer: nutrition or Pharmacology?

References

• Key Statistics for Lung Cancer; 2019.
   Google Scholar
• Prognosis and Survival Rates | LungCancer.net; 2016.
   Google Scholar
• Non-Small Cell Lung Cancer; 2019.
   Google Scholar
• van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378(9804):1741–55. doi:10.1016/S0140-6736(11)60165-7
   PubMed Web of Science ®Google Scholar
• Peters JM, Thomas D, Falk H, Oberdörster G, Smith TJ. Contribution of metals to respiratory cancer. Environ Health Perspect. 1986;70:71–83. doi:10.1289/ehp.867071
   PubMed Web of Science ®Google Scholar
• NIH Categorical Spending -NIH Research Portfolio Online Reporting Tools (RePORT).
   Google Scholar
• Nagle CM, Wilson LF, Hughes MCB, Ibiebele TI, Miura K, Bain CJ, Whiteman DC, Webb PM. Cancers in Australia in 2010 attributable to inadequate consumption of fruit, non-starchy vegetables and dietary fibre. Aust N Z J Public Health. 2015;39(5):422–8. doi:10.1111/1753-6405.12449
   PubMed Web of Science ®Google Scholar
• Behrouzian B, Buist PH. Mechanism of fatty acid desaturation: A bioorganic perspective. Prostaglandins Leukotrienes and Essential Fatty Acids. 2003;68(2):107–12. doi:10.1016/S0952-3278(02)00260-0
   PubMed Web of Science ®Google Scholar
• Mihelich ED. Structure and stereochemistry of novel endoperoxides isolated from the sensitized photooxidation of methyl linoleate. implications for prostaglandin biosynthesis. J Am Chem Soc. 1980;102(23):7141–3. doi:10.1021/ja00543a061
   Web of Science ®Google Scholar
• Sacks FM, Campos H. Polyunsaturated fatty acids, inflammation, and cardiovascular disease: Time to widen our view of the mechanisms. J Clin Endocrinol Metab . 2006;91(2):398–400. doi:10.1210/jc.2005-2459
   PubMed Web of Science ®Google Scholar
• Kew S, et al. Printed in USA. Am J Clin Nutr. 2003;77: 4230–4238.
   Google Scholar
• Omega-3 Fatty Acids — Consumer. Available from: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer/
   Google Scholar
• Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PRC. Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. In Lipids. 2003;38(4):391–8. American Oil Chemists Society, doi:10.1007/s11745-003-1074-0
   PubMed Web of Science ®Google Scholar
• Chiu C-C, Su K-P, Cheng T-C, Liu H-C, Chang C-J, Dewey ME, Stewart R, Huang S-Y. The effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study. Prog. Neuro-Psychopharmacol Biol. Psychiatry. 2008;32(6):1538–44. doi:10.1016/j.pnpbp.2008.05.015
   PubMed Web of Science ®Google Scholar
• Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008;197(1):12–24. doi:10.1016/j.atherosclerosis.2007.11.008
   PubMed Web of Science ®Google Scholar
• Liu G, Bibus DM, Bode AM, Ma W-Y, Holman RT, Dong Z. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proc Natl Acad Sci USA. 2001;98(13):7510–5. doi:10.1073/pnas.131195198
   PubMed Web of Science ®Google Scholar
• Wood LG, Attia J, McElduff P, McEvoy M, Gibson PG. Assessment of dietary fat intake and innate immune activation as risk factors for impaired lung function. Eur J Clin Nutr. 2010;64(8):818–25. doi:10.1038/ejcn.2010.68
   PubMed Web of Science ®Google Scholar
• Best KP, Sullivan T, Palmer D, Gold M, Kennedy D, Martin J, Makrides M. Prenatal fish oil supplementation and allergy: 6-Year follow-up of a randomized controlled trial. Pediatrics. 2016;137(6):e20154443–e20154443. doi:10.1542/peds.2015-4443
   PubMed Web of Science ®Google Scholar
• Pontes-Arruda A, DeMichele S, Seth A, Singer P. The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. J Parenter Enteral Nutr. 2008;32(6):596–605. doi:10.1177/0148607108324203
   PubMed Web of Science ®Google Scholar
• Garcia-Larsen V, Amigo H, Bustos P, Bakolis I, Rona RJ. Ventilatory function in young adults and dietary antioxidant intake. Nutrients. 2015;7(4):2879–96. doi:10.3390/nu7042879
   PubMed Web of Science ®Google Scholar
• Leng S, Picchi MA, Tesfaigzi Y, Wu G, Gauderman WJ, Xu F, Gilliland F, Belinsky SA. Dietary nutrients associated with preservation of lung function in hispanic and Non-Hispanic white smokers from New Mexico. COPD. 2017;Volume 12:3171–81. doi:10.2147/COPD.S142237
   Google Scholar
• Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modification: Implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA. 1990;87(10):3894–8. doi:10.1073/pnas.87.10.3894
   PubMed Web of Science ®Google Scholar
• Alnabulsi A, Swan R, Cash B, Alnabulsi A, Murray GI. The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance. Br J Cancer. 2017;116(12):1612–20. doi:10.1038/bjc.2017.135
   PubMed Web of Science ®Google Scholar
• Harris WS. The omega-6/omega-3 ratio and cardiovascular disease risk: Uses and abuses. Curr Atheroscler Rep. 2006;8(6):453–9. doi:10.1007/s11883-006-0019-7
   PubMedGoogle Scholar
• Kiss NK, Krishnasamy M, Isenring EA. The effect of nutrition intervention in lung cancer patients undergoing chemotherapy and/or radiotherapy: a systematic review. Nutrit Cancer. 2014;66(1):47–56. doi:10.1080/01635581.2014.847966
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Okamoto T, Fujishita T, Katsura M, Akamine T, Takamori S, Morodomi Y, Tagawa T, Shoji F, Maehara Y, et al. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer. Lung Cancer. 2016;101:92–7. Elsevier. doi:10.1016/j.lungcan.2016.08.007
   PubMed Web of Science ®Google Scholar
• Murphy RA, Mourtzakis M, Chu QS, Reiman T, Mazurak VC. skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. J. Nutr. 2010;140(9):1602–6. doi:10.3945/jn.110.123521
   PubMed Web of Science ®Google Scholar
• Roodhart JML, Daenen LGM, Stigter ECA, Prins H-J, Gerrits J, Houthuijzen JM, Gerritsen MG, Schipper HS, Backer MJG, van Amersfoort M, et al. Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids. Cancer Cell. 2011;20(3):370–83. doi:10.1016/j.ccr.2011.08.010
   PubMed Web of Science ®Google Scholar
• van der Meij BS, Langius JAE, Spreeuwenberg MD, Slootmaker SM, Paul MA, Smit EF, van Leeuwen PAM. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: An RCT. Eur J Clin Nutr. 2012;66(3):399–404. doi:10.1038/ejcn.2011.214
   PubMed Web of Science ®Google Scholar
• van der Meij BS, Langius JAE, Smit EF, Spreeuwenberg MD, von Blomberg BME, Heijboer AC, Paul MA, van Leeuwen PAM. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment. J. Nutr. 2010;140(10):1774–80. doi:10.3945/jn.110.121202
   PubMed Web of Science ®Google Scholar
• Kobayakawa M, Yamawaki S, Hamazaki K, Akechi T, Inagaki M, Uchitomi Y. Levels of omega-3 fatty acid in serum phospholipids and depression in patients with lung cancer. Br J Cancer. 2005;93(12):1329–33. doi:10.1038/sj.bjc.6602877
   PubMed Web of Science ®Google Scholar
• Suzuki S, Akechi T, Kobayashi M. … K. T.-B. journal of & 2004. undefined. Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer. nature.com.
   Google Scholar
• Liao Y, et al. Efficacy of omega-3 PUFAs in depression: a meta-analysis. Transl. Psychiatry. 2019;9:190–198.
   PubMed Web of Science ®Google Scholar
• Deacon G, Kettle C, Hayes D, Dennis C, Tucci J. Omega 3 polyunsaturated fatty acids and the treatment of depression. Crit Rev Food Sci Nutr. 2017;57(1):212–23. doi:10.1080/10408398.2013.876959
   PubMed Web of Science ®Google Scholar
• Kaya SO, et al. Is preoperative protein-rich nutrition effective on postoperative outcome in non-small cell lung cancer surgery? A prospective randomized study. J. Cardiothorac. Surg. 2016;11:14–21.
   PubMed Web of Science ®Google Scholar
• Sánchez-Lara K, Turcott JG, Juárez-Hernández E, Nuñez-Valencia C, Villanueva G, Guevara P, De la Torre-Vallejo M, Mohar A, Arrieta O. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: RANDOMISED trial. Clin Nutr. 2014;33(6):1017–23. doi:10.1016/j.clnu.2014.03.006
   PubMed Web of Science ®Google Scholar
• Finocchiaro C, Segre O, Fadda M, Monge T, Scigliano M, Schena M, Tinivella M, Tiozzo E, Catalano MG, Pugliese M, et al. Effect of n-3 fatty acids on patients with advanced lung cancer: A double-blind, placebo-controlled study. Br J Nutr. 2012;108(2):327–33. doi:10.1017/S0007114511005551
   PubMed Web of Science ®Google Scholar
• Pastore CA, Orlandi SP, Gonzalez MC. Introduction of an omega-3 enriched oral supplementation for cancer patients close to the first chemotherapy: May it be a factor for poor compliance? Nutr Cancer. 2014;66(8):1285–92. doi:10.1080/01635581.2014.956253
   PubMed Web of Science ®Google Scholar
• Payne M, Ellis P, Dunlop D, Ranson M, Danson S, Schacter L, Talbot D. DHA-Paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trial. J Thorac Oncol. 2006;1(9):984–90. doi:10.1016/S1556-0864(15)31631-2
   PubMed Web of Science ®Google Scholar
• Price K, Azzoli C, Cardiovascular LG-S, In t. and & 2008. undefined. Chemoradiation for unresectable stage III non-small cell lung cancer. Elsevier.
   Google Scholar
• Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, Smith IE, O'Brien MER. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?. Br J Cancer. 2004;90(10):1905–11. doi:10.1038/sj.bjc.6601781
   PubMed Web of Science ®Google Scholar
• Bo L, Jiang S, Xie Y, Kan H, Song W, Zhao J. Effect of Vitamin E and omega-3 fatty acids on protecting ambient PM2.5-induced inflammatory response and oxidative stress in vascular endothelial cells. PLoS One. 2016;11(3):e0152216. doi:10.1371/journal.pone.0152216
   PubMed Web of Science ®Google Scholar
• Murphy RA, Yeung E, Mazurak VC, Mourtzakis M. Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia. Br J Cancer. 2011;105(10):1469–73. doi:10.1038/bjc.2011.391
   PubMed Web of Science ®Google Scholar
• Murphy RA, Mourtzakis M, Chu QSC, Baracos VE, Reiman T, Mazurak VC. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer. 2011;117(8):1775–82. doi:10.1002/cncr.25709
   PubMed Web of Science ®Google Scholar
• MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, Lim Y-W, Traina SB, Hilton L, Garland R, et al. Effects of omega-3 fatty acids on cancer risk: A systematic review. J Amer Med Assoc. 2006;295(4):403–15.
   Web of Science ®Google Scholar
• Veierød MB, Laake P, Thelle DS. Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women. Eur J Cancer Prev. 1997;6(6):540–9. doi:10.1097/00008469-199712000-00009
   PubMed Web of Science ®Google Scholar
• Zuijdgeest-VAN Leeuwen SD, VAN DER Heijden MS, Rietveld T, VAN DEN Berg JWO, Tilanus HW, Burgers JA, Paul Wilson JH, Dagnelie PC. Fatty acid composition of plasma lipids in patients with pancreatic, lung and oesophageal cancer in comparison with healthy subjects. Clin. Nutr. 2002;21(3):225–30. doi:10.1054/clnu.2001.0530
   PubMed Web of Science ®Google Scholar
• Patchen B, et al. Positive associations of dietary marine omega-3 polyunsaturated fatty acids with lung function: a meta-analysis (P18-087-19). Curr Dev Nutr. 2019;3(Suppl 1): nzz039.P18-087-19.
   Google Scholar
• Hardman WE. (n-3) Fatty acids and cancer therapy. J Nutr. 2004;134(12):3427S–30S. doi:10.1093/jn/134.12.3427S
   PubMed Web of Science ®Google Scholar
• Louzada S, Adega F, Chaves R. Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an In Vitro cell model for Erbb2. PLoS One. 2012;7(1):e29923. doi:10.1371/journal.pone.0029923
   PubMed Web of Science ®Google Scholar
• Bégin ME, Das UN, Ells G, Horrobin DF. Selective killing of human cancer cells by polyunsaturated fatty acids. Prostaglandins, Leukot Med. 1985;19(2):177–86. doi:10.1016/0262-1746(85)90084-8
   PubMedGoogle Scholar
• Trombetta A, Maggiora M, Martinasso G, Cotogni P, Canuto RA, Muzio G. Arachidonic and docosahexaenoic acids reduce the growth of A549 human lung-tumor cells increasing lipid peroxidation and PPARs. Chem Biol Interact. 2007;165(3):239–50. doi:10.1016/j.cbi.2006.12.014
   PubMed Web of Science ®Google Scholar
• Fearon KCH, Glass DJ, Guttridge DC. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 2012;16(2):153–66. doi:10.1016/j.cmet.2012.06.011
   PubMed Web of Science ®Google Scholar
• Muzio G, Ricci M, Traverso N, Monacelli F, Oraldi M, Maggiora M, Canuto RA. 4-Hydroxyhexenal and 4-hydroxynonenal are mediators of the anti-cachectic effect of n-3 and n-6 polyunsaturated fatty acids on human lung cancer cells. Free Radic. Biol. Med. 2016;99:63–70. doi:10.1016/j.freeradbiomed.2016.07.031
   PubMed Web of Science ®Google Scholar
• Arita K, Kobuchi H, Utsumi T, Takehara Y, Akiyama J, Horton AA, Utsumi K. Mechanism of apoptosis in HL-60 cells induced by n-3 and n-6 polyunsaturated fatty acids. Biochem Pharmacol. 2001;62(7):821–8.
   PubMed Web of Science ®Google Scholar
• Xia SH, Wang J, Kang JX. Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes. Carcinogenesis. 2005;26(4):779–84. doi:10.1093/carcin/bgi019
   PubMed Web of Science ®Google Scholar
• Zajdel A, Wilczok A, Tarkowski M. Toxic effects of n-3 polyunsaturated fatty acids in human lung A549 cells. Toxicol Vitr. 2015;30(1):486–91. doi:10.1016/j.tiv.2015.09.013
   PubMed Web of Science ®Google Scholar
• Yin Y, Sui C, Meng F, Ma P, Jiang Y. The omega-3 polyunsaturated fatty acid docosahexaenoic acid inhibits proliferation and progression of non-small cell lung cancer cells through the reactive oxygen species-mediated inactivation of the PI3K /Akt pathway. Lipids Health Dis. 2017;16(1):87–95. doi:10.1186/s12944-017-0474-x
   PubMed Web of Science ®Google Scholar
• Loda M, Capodieci P, Mishra R, Yao H, Corless C, Grigioni W, Wang Y, Magi-Galluzzi C, Stork PJ. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am J Pathol. 1996;149(5):1553–64.
   PubMed Web of Science ®Google Scholar
• Pelicano H, Martin DS, Xu R-H, Huang P. Glycolysis inhibition for anticancer treatment. Oncogene. 2006;25(34):4633–46. doi:10.1038/sj.onc.1209597
   PubMed Web of Science ®Google Scholar
• Guo YL, Kang B, Williamson JR. Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-α in rat mesangial cells. J Biol Chem. 1998;273(17):10362–6. doi:10.1074/jbc.273.17.10362
   PubMed Web of Science ®Google Scholar
• Wahab N, Cox D, Witherden A, Mason RM. Connective tissue growth factor (CTGF) promotes activated mesangial cell survival via up-regulation of mitogen-activated protein kinase phosphatase-1 (MKP-1). Biochem J. 2007;406(1):131–8. doi:10.1042/BJ20061817
   PubMed Web of Science ®Google Scholar
• Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene. 2004;23(16):2838–49. doi:10.1038/sj.onc.1207556
   PubMed Web of Science ®Google Scholar
• Pardini RS, Wilson D, Schiff S, Bajo SA, Pierce R. Nutritional intervention with omega-3 fatty acids in a case of malignant fibrous histiocytoma of the lungs. Nutr Cancer. 2005;52(2):121–9. doi:10.1207/s15327914nc5202_2
   PubMed Web of Science ®Google Scholar
• Serini S, Trombino S, Oliva F, Piccioni E, Monego G, Resci F, Boninsegna A, Picci N, Ranelletti FO, Calviello G, et al. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression. Apoptosis. 2008;13(9):1172–83. doi:10.1007/s10495-008-0246-1
   PubMed Web of Science ®Google Scholar
• DuBois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Putte LBA, Lipsky PE. Cyclooxygenase in biology and disease. FASEB J. 1998;12(12):1063–73. doi:10.1096/fasebj.12.12.1063
   PubMed Web of Science ®Google Scholar
• Horrobin DF. The reversibility of cancer: The relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1. Med Hypotheses. 1980;6(5):469–86. doi:10.1016/0306-9877(80)90099-7
   PubMed Web of Science ®Google Scholar
• Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Therapeut. 1999;83(3):217–44. doi:10.1016/S0163-7258(99)00026-1
   PubMed Web of Science ®Google Scholar
• Yang P, Chan D, Felix E, Cartwright C, Menter DG, Madden T, Klein RD, Fischer SM, Newman RA. Formation and antiproliferative effect of prostaglandin E3 from eicosapentaenoic acid in human lung cancer cells. J Lipid Res. 2004;45(6):1030–9. doi:10.1194/jlr.M300455-JLR200
   PubMed Web of Science ®Google Scholar
• Yang J, Solaimani P, Dong H, Hammock B, Hankinson O. Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung. J Toxicol Sci. 2013;38(6):833–6. doi:10.2131/jts.38.833
   PubMed Web of Science ®Google Scholar
• Kawata M, Koinuma D, Ogami T, Umezawa K, Iwata C, Watabe T, Miyazono K. TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells. J Biochem. 2012;151(2):205–16. doi:10.1093/jb/mvr136
   PubMed Web of Science ®Google Scholar
• Ikushima H, Miyazono K. TGFΒ 2 signalling: A complex web in cancer progression. Nat Rev Cancer. 2010;10(6):415–24. doi:10.1038/nrc2853
   PubMed Web of Science ®Google Scholar
• Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD, Helfrich BA, Garrett-Mayer E, Bunn PA, Drabkin HA, et al. ZEB1-responsive genes in non-small cell lung cancer. Cancer Lett. 2011;300(1):66–78. doi:10.1016/j.canlet.2010.09.007
   PubMed Web of Science ®Google Scholar
• Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, Flower RJ, Perretti M, Serhan CN. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature. 2009;461(7268):1287–91. doi:10.1038/nature08541
   PubMed Web of Science ®Google Scholar
• Lee HJ, Park MK, Lee EJ, Lee CH. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. Int J Biochem Cell Biol. 2013;45(12):2801–7. doi:10.1016/j.biocel.2013.09.018
   PubMed Web of Science ®Google Scholar
• Barhoumi R, Mouneimne Y, Chapkin RS, Burghardt RC. Effects of fatty acids on benzo[a]pyrene uptake and metabolism in human lung adenocarcinoma A549 cells. PLoS One. 2014;9(3):e90908. doi:10.1371/journal.pone.0090908
   PubMed Web of Science ®Google Scholar
• Denison MS, Soshilov AA, He G, Degroot DE, Zhao B. Exactly the same but different: Promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci. 2011;124(1):1–22. doi:10.1093/toxsci/kfr218
   PubMed Web of Science ®Google Scholar
• Huerta-Yépez S, Tirado-Rodriguez AB, Hankinson O. Role of diets rich in omega-3 and omega-6 in the development of cancer. Boletín Médico Del Hosp. Infant. México (English Ed.) 2016;73(6):446–56. doi:10.1016/j.bmhime.2017.11.043
   PubMed Web of Science ®Google Scholar
• Bui P, Solaimani P, Wu X, Hankinson O2. 3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicol Appl Pharmacol. 2012;259(2):143–51. doi:10.1016/j.taap.2011.12.009
   PubMed Web of Science ®Google Scholar
• Corpet DE, Pierre F. How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men. Eur J Cancer. 2005;41(13):1911–22. doi:10.1016/j.ejca.2005.06.006
   PubMed Web of Science ®Google Scholar
• Cekanova M, Rathore K. Animal models and therapeutic molecular targets of cancer: Utility and limitations. Drug Des Devel Ther. 2014;8:1911–22. doi:10.2147/DDDT.S49584
   PubMed Web of Science ®Google Scholar
• Takao K, Miyakawa T. Genomic responses in mouse models greatly mimic human inflammatory diseases. Proc Natl Acad Sci USA. 2015;112(4):1167–72. doi:10.1073/pnas.1401965111
   PubMed Web of Science ®Google Scholar
• Kang JX. Fat-1 transgenic mice: a new model for omega-3 research. Prostaglandins Leukot Essent Fat Acids. 2007;77(5/6):263–7. doi:10.1016/j.plefa.2007.10.010
   PubMed Web of Science ®Google Scholar
• Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: Could they reduce recurrence rates in oncological patients?. Ann Surg Oncol. 2003;10(8):972–92. doi:10.1245/ASO.2003.02.007
   PubMed Web of Science ®Google Scholar
• Goldfarb Y, Shapiro H, Singer P, Kalderon Y, Levi B, Glasner A, Benish M, Ben-Eliyahu S. Fish oil attenuates surgery-induced immunosuppression, limits post-operative metastatic dissemination and increases long-term recurrence-free survival in rodents inoculated with cancer cells. Clin Nutr. 2012;31(3):396–404. doi:10.1016/j.clnu.2011.10.015
   PubMed Web of Science ®Google Scholar
• Lee HH, Kang H, Cho H. Natural killer cells and tumor metastasis. Arch Pharm Res. 2017;40(9):1037–49. doi:10.1007/s12272-017-0951-9
   PubMed Web of Science ®Google Scholar
• Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 2000;19(1/2):19–27. ]
   PubMed Web of Science ®Google Scholar
• Krysan K, Dalwadi H, Sharma S, Põld M, Dubinett S. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer. Cancer Res. 2004;64(18):6359–62. doi:10.1158/0008-5472.CAN-04-1681
   PubMed Web of Science ®Google Scholar
• Baratelli F, Lin Y, Zhu L, Yang S-C, Heuzé-Vourc’h N, Zeng G, Reckamp K, Dohadwala M, Sharma S, Dubinett SM, et al. Prostaglandin E 2 Induces FOXP3 Gene Expression and T Regulatory Cell Function in Human CD4 + T Cells. J Immunol. 2005;175(3):1483–90. doi:10.4049/jimmunol.175.3.1483
   PubMed Web of Science ®Google Scholar
• Yang P, Cartwright C, Chan D, Ding J, Felix E, Pan Y, Pang J, Rhea P, Block K, Fischer SM, et al. Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation. Mol Carcinog. 2014;53(7):566–77. doi:10.1002/mc.22008
   PubMed Web of Science ®Google Scholar
• Vanamala J, Glagolenko A, Yang P, Carroll RJ, Murphy ME, Newman RA, Ford JR, Braby LA, Chapkin RS, Turner ND, et al. Dietary fish oil and pectin enhance colonocyte apoptosis in part through suppression of PPARδ/PGE2 and elevation of PGE3. Carcinogenesis. 2008;29(4):790–6. doi:10.1093/carcin/bgm256
   PubMed Web of Science ®Google Scholar
• Wendel M, Heller AR. Anticancer actions of omega-3 fatty acids - current state and future perspectives. 2009;9(4):457–470.
   Google Scholar
• Riediger ND, Othman RA, Suh M, Moghadasian MH. A Systemic Review of the Roles of n-3 Fatty Acids in Health and Disease. J Am Diet Assoc. 2009;109(4):668–79. doi:10.1016/j.jada.2008.12.022
   PubMed Web of Science ®Google Scholar
• Mouradian M, Kikawa KD, Johnson ED, Beck KL, Pardini RS. Key roles for GRB2-associated-binding protein 1, phosphatidylinositol-3-kinase, cyclooxygenase 2, prostaglandin E2 and transforming growth factor alpha in linoleic acid-induced upregulation of lung and breast cancer cell growth. Prostaglandins Leukot Essent Fat Acids. 2014;90(4):105–15. doi:10.1016/j.plefa.2013.12.001
   PubMed Web of Science ®Google Scholar
• Schwartz SA, Hernandez A, Mark Evers B. The role of NF-κB/IκB proteins in cancer: Implications for novel treatment strategies. Surg Oncol. 1999;8(3):143–53. doi:10.1016/S0960-7404(00)00012-8
   PubMed Web of Science ®Google Scholar
• Szymczak M, Murray M, Petrovic N. Modulation of angiogenesis by ω-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood. 2008;111(7):3514–21. doi:10.1182/blood-2007-08-109934
   PubMed Web of Science ®Google Scholar
• Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA. 2003;100(4):1751–6. doi:10.1073/pnas.0334211100
   PubMed Web of Science ®Google Scholar
• Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu J-Y, Stephen Lee KS, Wettersten HI, Ulu A, Hu X, Tam S, et al. Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci USA. 2013;110(16):6530–5. doi:10.1073/pnas.1304321110
   PubMed Web of Science ®Google Scholar
• Roy J, Watson JE, Hong IS, Fan TM, Das A. Anti-tumorigenic properties of omega-3 endocannabinoid epoxides anti-inflammatory lipid metabolites view project membrane protein mechanism view project. J Med Chem. 2018;61(13):5569–79. doi:10.1021/acs.jmedchem.8b00243
   PubMed Web of Science ®Google Scholar
• Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome Formation in Mammalian Cells. Cell Struct Funct. 2002;27(6):421–9. doi:10.1247/csf.27.421
   PubMed Web of Science ®Google Scholar
• Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov. 2006;5(8):671–88. doi:10.1038/nrd2062
   PubMed Web of Science ®Google Scholar
• Kim N, Jeong S, Jing K, Shin S, Kim S, Heo J-Y, Kweon G-R, Park S-K, Wu T, Park J-I, et al. Docosahexaenoic acid induces cell death in human non-small cell lung cancer cells by repressing mTOR via AMPK activation and PI3K/Akt inhibition. Biomed Res. Int. 2015;2015:1–14. doi:10.1155/2015/239764
   Web of Science ®Google Scholar
• Lemons JA, for the NICHD Neonatal Research Network, et al. Very low birth weight outcomes of the national institute of child health and human development neonatal research network, January 1995 Through December 1996. Pediatrics. 2001;107(1):e1–e1., Bauer CR, Oh W, Korones SB, Papile L-A, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA,. doi:10.1542/peds.107.1.e1
   PubMed Web of Science ®Google Scholar
• Kul M, Gönül E, Akcan AB, Küçükodacı Z, Süleymanoğlu S. The effects of omega-3 fatty acids on the newborn rat hyperoxic lung injury. J Maternal–Fetal Neonatal Med. 2019;6:1–7. doi:10.1080/14767058.2018.1554042
   Web of Science ®Google Scholar
• Sadeghi S, Wallace FA, Calder PC. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology. 1999;96:404–10.
   PubMed Web of Science ®Google Scholar